Index
RUT
P/E
-
EPS (ttm)
-0.72
Insider Own
28.23%
Shs Outstand
147.50M
Perf Week
-0.80%
Market Cap
1.29B
Forward P/E
-
EPS next Y
-0.09
Insider Trans
-0.07%
Shs Float
105.86M
Perf Month
13.96%
Enterprise Value
1.55B
PEG
-
EPS next Q
-0.04
Inst Own
73.11%
Perf Quarter
61.69%
Income
-104.56M
P/S
6.28
EPS this Y
60.65%
Inst Trans
-2.03%
Perf Half Y
33.51%
Sales
204.73M
P/B
3.47
EPS next Y
18.67%
ROA
-12.50%
Perf YTD
53.23%
Book/sh
1.43
P/C
7.75
EPS next 5Y
43.44%
ROE
-40.83%
52W High
5.30 -6.04%
Perf Year
120.35%
Cash/sh
0.64
P/FCF
-
EPS past 3/5Y
- -
ROIC
-21.92%
52W Low
1.99 150.25%
Perf 3Y
-64.81%
Dividend Est.
-
EV/EBITDA
91.07
Sales past 3/5Y
-40.53% -8.15%
Gross Margin
28.41%
Volatility
5.72% 5.34%
Perf 5Y
-88.86%
Dividend TTM
-
EV/Sales
7.56
EPS Y/Y TTM
37.09%
Oper. Margin
-20.29%
ATR (14)
0.26
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
4.96
Sales Y/Y TTM
-15.35%
Profit Margin
-51.07%
RSI (14)
63.66
Dividend Gr. 3/5Y
- -
Current Ratio
5.91
EPS Q/Q
87.79%
SMA20
6.19%
Beta
0.67
Payout
-
Debt/Eq
1.28
Sales Q/Q
40.53%
SMA50
22.63%
Rel Volume
0.69
Prev Close
5.21
Employees
435
LT Debt/Eq
1.25
SMA200
44.03%
Avg Volume
2.42M
Price
4.98
IPO
Nov 20, 2020
Option/Short
Yes / Yes
Trades
Volume
1,675,469
Change
-4.41%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-25 Downgrade Robert W. Baird
Outperform → Neutral
$9 → $3
Dec-19-24 Initiated Guggenheim
Neutral
Dec-05-24 Downgrade Goldman
Neutral → Sell
$4.25
Nov-14-24 Initiated Wolfe Research
Peer Perform
Nov-08-24 Downgrade William Blair
Outperform → Mkt Perform
Aug-28-24 Initiated Wells Fargo
Overweight
$10
Aug-13-24 Downgrade Morgan Stanley
Overweight → Equal-Weight
$11 → $10
Apr-10-24 Initiated Craig Hallum
Buy
$15
Dec-12-23 Upgrade BofA Securities
Neutral → Buy
$10 → $8
Aug-08-23 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
May-23-23 Downgrade Credit Suisse
Outperform → Neutral
$18 → $14
May-09-23 Downgrade Goldman
Buy → Neutral
Jan-05-23 Downgrade UBS
Buy → Neutral
$20 → $16
Dec-14-22 Initiated Deutsche Bank
Buy
$25
Dec-07-22 Initiated RBC Capital Mkts
Outperform
$22
Nov-03-22 Downgrade BofA Securities
Buy → Neutral
$32 → $17
Aug-25-22 Initiated Credit Suisse
Outperform
$34
Aug-05-21 Resumed Credit Suisse
Outperform
$44
Dec-16-20 Initiated KeyBanc Capital Markets
Overweight
$33
Dec-15-20 Initiated William Blair
Outperform
Show Previous Ratings
Jun-03-26 08:30AM
May-18-26 04:00PM
May-08-26 08:30AM
May-07-26 04:01PM
Apr-20-26 04:05PM
08:30AM
Loading…
Feb-26-26 08:30AM
02:11AM
Feb-25-26 07:25PM
04:01PM
Feb-09-26 05:05PM
Nov-10-25 08:00AM
Nov-07-25 12:12AM
Nov-06-25 06:15PM
04:01PM
Nov-04-25 09:05AM
04:01PM
Loading…
Oct-22-25 04:01PM
Aug-12-25 03:07AM
Aug-11-25 07:00PM
04:05PM
Jul-28-25 05:08PM
Jun-25-25 04:01PM
Jun-09-25 08:30AM
Jun-03-25 10:00AM
May-21-25 04:22PM
04:05PM
May-20-25 08:00AM
May-14-25 04:00PM
May-13-25 09:30AM
(Thomson Reuters StreetEvents)
03:11AM
May-12-25 05:20PM
04:06PM
Loading…
04:06PM
May-08-25 05:10PM
May-07-25 07:10PM
May-05-25 05:47AM
May-01-25 05:20PM
07:30AM
Apr-24-25 12:27PM
Apr-22-25 05:45AM
Apr-16-25 06:10PM
Apr-15-25 09:35AM
Apr-14-25 01:13PM
Apr-11-25 01:31PM
Apr-10-25 11:34AM
04:37AM
Apr-04-25 02:34PM
Apr-03-25 06:21PM
Apr-01-25 01:23PM
Mar-26-25 11:10AM
Mar-25-25 12:49PM
Mar-24-25 02:33PM
Mar-22-25 10:30AM
Mar-21-25 08:00PM
01:43PM
Mar-20-25 09:00PM
Mar-18-25 04:05PM
05:45AM
Mar-17-25 02:22AM
Mar-16-25 09:32AM
Mar-08-25 10:15AM
Feb-28-25 09:31AM
Feb-27-25 06:37PM
Feb-25-25 06:00AM
Feb-24-25 08:00AM
Feb-04-25 04:01PM
Feb-03-25 06:00AM
Jan-28-25 04:01PM
Jan-20-25 11:02PM
Jan-08-25 04:10PM
Dec-20-24 07:15AM
Dec-05-24 04:05PM
Nov-12-24 08:05AM
Nov-09-24 06:51AM
Nov-08-24 02:20PM
(Thomson Reuters StreetEvents)
-35.27%
03:15AM
02:34AM
Nov-07-24 04:01PM
04:01PM
Oct-15-24 04:05PM
Oct-09-24 08:03AM
Sep-24-24 08:12AM
Aug-28-24 07:49AM
Aug-12-24 08:05AM
Aug-08-24 12:45AM
Aug-07-24 04:05PM
Jul-29-24 04:05PM
Jul-10-24 08:00AM
Jul-02-24 04:00PM
Jun-20-24 09:15AM
Jun-17-24 09:54AM
Jun-12-24 02:38AM
May-17-24 11:52AM
May-13-24 08:00AM
May-09-24 04:18PM
(Insider Monkey)
+11.16%
+6.09%
04:05PM
10:53AM
10:11AM
04:02AM
03:15AM
May-08-24 08:57PM
04:05PM
Maravai Lifesciences Holdings, Inc. engages in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm's brands include TriLink BioTechnologies, Cygnus, Glen Research, and Alphazyme. It operates through the TriLink and Cygnus segments. The TriLink segment manufactures and sells products used in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Cygnus segment sells biologic safety testing products and highly specialized analytical products for use in biologic manufacturing process development, including custom product-specific antibody and assay development services. It also operates through the following geographical segments: North America, Asia Pacific, Europe, the Middle East, and Africa, and Latin and Central America. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Chairman of the Board Mr. Robert Andrew Eckert M.B.A.
CEO & Director Mr. Bernd Brust
EVP & Chief Financial Officer Mr. Rajesh J. Asorpota
Executive VP Mr. Kurt A. Oreshack J.D.
Executive VP & GM of Cygnus Technologies Ms. Christine Dolan
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ORESHACK KURT General Counsel Jun 10 '26 Sale 5.10 25,000 127,500 335,767 Jun 10 05:06 PM ORESHACK KURT General Counsel Jun 09 '26 Sale 5.06 25,000 126,500 360,767 Jun 10 05:06 PM ORESHACK KURT Officer Jun 10 '26 Proposed Sale 5.10 25,000 127,500 Jun 10 12:00 PM ORESHACK KURT Officer Jun 09 '26 Proposed Sale 5.06 25,000 126,500 Jun 09 10:31 AM PRAHALAD MURALI Former Director Dec 23 '25 Proposed Sale 3.33 3,951 13,138 Dec 23 03:00 PM Hopfield Jessica Former Director Dec 19 '25 Proposed Sale 3.48 53,951 187,526 Dec 19 04:38 PM LUCIER GREGORY T Director Dec 05 '25 Buy 3.70 51,472 190,446 106,595 Dec 09 04:36 PM LUCIER GREGORY T Director Dec 08 '25 Buy 3.67 48,528 178,098 155,123 Dec 09 04:36 PM Brust Bernd Chief Executive Officer Nov 13 '25 Buy 3.25 216,212 702,689 466,771 Nov 17 04:48 PM Brust Bernd Chief Executive Officer Nov 11 '25 Buy 3.24 157,201 509,331 157,201 Nov 13 05:27 PM Brust Bernd Chief Executive Officer Nov 12 '25 Buy 3.21 93,358 299,679 250,559 Nov 13 05:27 PM
